BioLineRx Ltd. BLRX
Set alert
1.96 USD -0.03 -1.51%
At close
1.96 0.00 0.00%
Pre-market · Nov 3, 4:01 AM ET
1.94 Day range 1.96
1.94 52-week range 3.95
- YTD
- -29.24%
- 1 year
- -43.52%
- Open
- 1.94
- Prev close
- 1.99
- Mkt cap
- 9.76M
- Vol
- 4.70K
- Avg vol
- 16.93K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.94
- High
- 1.96
- Forward P/E
- -1.06
- Beta
- 0.87
- Short ratio
- 2.39
- Inst. own
- 3.09%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.3624
- 200-d avg
- 0.62615
- 1y target
- 4.57
6M chart
Signals (25)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 22, 2026 | 1 week ago |
| RSI: Oversold | Oct 14, 2026 | 2 weeks ago |
| MACD: Sell Signal | Sep 29, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 24, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 3, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 31, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| SMA: Bearish | Aug 25, 2026 | 2 months ago |
| SMA: Bearish | Aug 25, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| SMA: Bearish | Aug 20, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bearish | Jul 24, 2026 | 3 months ago |
| SMA: Bullish | Jul 21, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jul 8, 2026 | 3 months ago |
| MACD: Sell Signal | Jun 5, 2026 | 5 months ago |
| RSI: Overbought | May 29, 2026 | 5 months ago |
Newest 20 of 25.
Analyst view
Consensus: none
Price target (mean) 4.57 +133.0% upside
Now 1.96
- Target (low)
- 2.00
- Target (mean)
- 4.57
- Target (high)
- 9.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
- 2 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -0.0894 | +100.0% | 7.72M | +60.8% | 1 |
| Next quarter | -0.03 | -0.03 – -0.03 | 0.00 | 0.0% | 792.00K | -88.4% | 1 |
| Current year | -0.08 | -0.08 – -0.08 | -0.8394 | +90.5% | 24.91M | +419.0% | 1 |
| Next year | -0.11 | -0.11 – -0.11 | -0.08 | -37.5% | 4.29M | -82.8% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 25, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 3, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 29, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 17, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 26, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 29, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 20, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 15, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 31, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 25, 2023 | Oppenheimer | Reiterated | — | Outperform |
| Feb 23, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Dec 16, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Aug 4, 2017 | Oppenheimer | Initiated | — | Outperform |
| May 18, 2017 | Maxim Group | Upgrade | Hold | Buy |
| Feb 13, 2017 | Rodman & Renshaw | Initiated | — | Buy |
| Aug 12, 2016 | Maxim Group | Downgrade | Buy | Hold |
| Mar 9, 2016 | JMP Securities | Maintained | — | Market Outperform |
| Jun 22, 2015 | JMP Securities | Initiated | — | Outperform |
| Jun 22, 2015 | JP Morgan | Initiated | — | Market Outperform |